Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.

Ulrickson M, Press OW, Casper C.

Adv Hematol. 2012;2012:932658. doi: 10.1155/2012/932658. Epub 2012 Mar 26.

2.

The increasing burden of HIV-associated malignancies in resource-limited regions.

Casper C.

Annu Rev Med. 2011;62:157-70. doi: 10.1146/annurev-med-050409-103711. Review.

PMID:
20868276
3.

The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.

Vilchez RA, Finch CJ, Jorgensen JL, Butel JS.

Medicine (Baltimore). 2003 Mar;82(2):77-81.

4.

AIDS-associated cancer in developing nations.

Orem J, Otieno MW, Remick SC.

Curr Opin Oncol. 2004 Sep;16(5):468-76. Review.

PMID:
15314517
5.

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.

Jacobson CA, Abramson JS.

Adv Hematol. 2012;2012:507257. doi: 10.1155/2012/507257. Epub 2012 Jan 5.

6.

Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.

Pluda JM, Yarchoan R, Jaffe ES, Feuerstein IM, Solomon D, Steinberg SM, Wyvill KM, Raubitschek A, Katz D, Broder S.

Ann Intern Med. 1990 Aug 15;113(4):276-82.

PMID:
1973886
7.

Advances in the management of HIV-related non-Hodgkin lymphoma.

Behler CM, Kaplan LD.

Curr Opin Oncol. 2006 Sep;18(5):437-43. Review.

PMID:
16894290
8.

Epidemiologic trends in HIV-associated lymphomas.

Clarke CA, Glaser SL.

Curr Opin Oncol. 2001 Sep;13(5):354-9. Review.

PMID:
11555712
9.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

10.

Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.

Rochford R, Feuer G, Orem J, Banura C, Katongole-Mbidde E, Mwanda WO, Moormann A, Harrington WJ, Remick SC.

East Afr Med J. 2005 Sep;82(9 Suppl):S155-60. Review.

PMID:
16619692
11.
12.

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK.

N Engl J Med. 2005 Feb 10;352(6):570-85.

13.

Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.

Otieno MW, Banura C, Katongole-Mbidde E, Johnson JL, Ghannoum M, Dowlati A, Renne R, Arts E, Whalen C, Lederman MM, Remick SC.

J Natl Cancer Inst. 2002 May 15;94(10):718-32. Review.

14.

Epidemiology of HIV associated non-Hodgkin lymphoma.

Obrams GI, Grufferman S.

Cancer Surv. 1991;10:91-102. Review.

PMID:
1821326
15.

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH.

J Natl Cancer Inst. 1997 Feb 19;89(4):301-7.

16.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
17.
18.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
19.

HIV-associated Hodgkin lymphoma.

Carbone A, Gloghini A, Serraino D, Spina M.

Curr Opin HIV AIDS. 2009 Jan;4(1):3-10. doi: 10.1097/COH.0b013e32831a722b. Review.

PMID:
19339934
20.

Modern management of non-Hodgkin lymphoma in HIV-infected patients.

Mounier N, Spina M, Gisselbrecht C.

Br J Haematol. 2007 Mar;136(5):685-98. Epub 2006 Dec 1. Review.

PMID:
17229246
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk